Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Leopoly Introduces LeoShape: Transforming Orthotics & Prosthetics with Cutting-Edge 3D design tech, Revolutionizing The Industry.


LeoShape, from Leopoly, Introduces Innovative 3D Platform for Custom Orthotics & Prosthetics Design, Offering Free Trials in May

SAN MATEO, Calif., May 6, 2024 /PRNewswire-PRWeb/ -- Leopoly, a leading innovator in 3D modeling and extended reality (XR) software solutions, unveils its new product line,LeoShape, marking a significant milestone in the orthotics and prosthetics (O&P) sector. Developed as a Smart CAD solution, this innovative platform enables businesses to digitize, simplify, and automate the production process of custom-fabricated wearables. LeoShape is a groundbreaking advancement in O&P, offering a state-of-the-art 3D design engine that is set to redefine the design and manufacturing processes in the O&P industry.

"LeoShape is committed to reshaping the future of orthotics and prosthetics through digital innovation," stated Roland Manyai, CEO of LeoShape. "Our 3D design engine is equipped to meet the evolving needs of practitioners and patients alike, ensuring superior customization and quality in O&P care."

At the heart of LeoShape's innovation is its proprietary 3D design engine, which provides unmatched flexibility for producing insoles, Ankle-Foot Orthotics (AFOs), and spinal braces, among other O&P devices. Boldly advancing the capabilities of the O&P industry, LeoShape's design engine is purpose-built to transform how professionals craft and customize their devices.

Its modular system enables the processing of 3D scans with unprecedented precision. Features like AI-supported geometry search, template fitting, and comprehensive measurement tools are just the start, facilitating the creation of devices that are functionally superior and intricately tailored to individual needs. This enhances accessibility, efficiency, and scalability to meet the needs of practices or labs of any size while ensuring smooth operation across all devices.

"I began using the LeoShape's Insole platform approximately 3 months ago. I searched a wide array of companies and found the staff at LeoShape to be the most accommodating and willing to form a true partnership. Since I launched the software in my practice, the success is immeasurable. The ease of the software made the learning curve simple, and the inserts have been met with overwhelming satisfaction. The staff has been very receptive to my feedback and has worked to customize the platform to my clinical needs. I am very pleased with both the company and the software and look forward to the future advancements they will offer for my practice." Joe Terpenning - Infinite Technologies Orthotics & Prosthetics

LeoShape's technology is already making significant inroads in the industry, with hundreds of clinics in the United States adopting its solutions. Partnerships with leading entities like HP, EdserLabs, and the new Wiky Solutions demonstrate the platform's value and effectiveness.

LeoShape is hard at work in the background of Arize, the semi-automated foot orthotics solution that has been growing in recent years and enables podiatrists to deliver high-quality 3D-printed foot orthotics to their patients in the US. Wiky Solutions has established a goal of delivering comprehensive orthotic and prosthetic solutions to professionals.

According to the World Health Organization (WHO), 0.5% of the global population, or approximately 39 million people, requires O&P services, yet only 1 in 10 have access to these essential healthcare solutions. The demand for O&P devices is projected to rise significantly due to aging populations and the increasing prevalence of diabetes and vascular diseases, which are leading causes of limb loss. LeoShape's next-gen 3D design platform addresses this critical gap by providing scalable and efficient digital solutions that can meet the growing global need. With the ability to enhance customization, drastically reduce design time, and reduce production times, LeoShape is positioned to transform the accessibility and quality of O&P care worldwide.

In a move to broaden access to its innovative solutions, LeoShape is initiating a free trial campaign, that will provide a hands-on experience of its digital workflow benefits. Participants will also receive three printed insole shells demonstrating the tangible advantages of LeoShape's digital approach.

Looking forward, LeoShape is set to showcase its advancements at upcoming major industry events, including OT World, (Halle 1 booth F39), May 14-17 in Germany, and AOPA (American Orthotic and Prosthetic Association), September 12-15, in Charlotte, North Carolina, signaling its commitment to global leadership in O&P digital solutions.

About LeoShape

LeoShape is a pioneering division of Leopoly specializing in digital solutions for the orthotics and prosthetics industry. With its innovative 3D design engine and web-based editor, LeoShape is revolutionizing how O&P devices are designed, produced, and implemented. By leveraging advanced technology and partnerships, LeoShape is committed to improving patient care and advancing the field of orthotics and prosthetics. For more information, visit https://leopoly.com/leoshape/.

Media Contact

Zsófia Mester, LeoShape by Leopoly, +36307917159, [email protected], https://leopoly.com/leoshape/

SOURCE LeoShape by Leopoly


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: